SE7703760L - Antibiotika - Google Patents

Antibiotika

Info

Publication number
SE7703760L
SE7703760L SE7703760A SE7703760A SE7703760L SE 7703760 L SE7703760 L SE 7703760L SE 7703760 A SE7703760 A SE 7703760A SE 7703760 A SE7703760 A SE 7703760A SE 7703760 L SE7703760 L SE 7703760L
Authority
SE
Sweden
Prior art keywords
inhibit
growth
cinerubin
aclacinomycin
streptomyces
Prior art date
Application number
SE7703760A
Other languages
English (en)
Other versions
SE436758B (sv
Inventor
H Umezawa
T Takeuchi
H Naganawa
M Ishizuka
N Shibamoto
T Oki
T Inui
Original Assignee
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chem Res Found filed Critical Microbial Chem Res Found
Publication of SE7703760L publication Critical patent/SE7703760L/sv
Publication of SE436758B publication Critical patent/SE436758B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/48—Streptomyces antibioticus ; Actinomyces antibioticus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/888—Streptomyces antibioticus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7703760A 1976-04-07 1977-03-31 Sett att framstella nya antracyklin-glykosid-antibiotika, benemnda ma 144-m 711 och ma 144-m 712, genom odling av streptomyces galilaeus ma 144-m 711 eller streptomyces sp me 505-he1 och extraktion och rening av bildade SE436758B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3968876A JPS52136159A (en) 1976-04-07 1976-04-07 Anti/malignanttumor containing the same as active ingredients

Publications (2)

Publication Number Publication Date
SE7703760L true SE7703760L (sv) 1977-10-08
SE436758B SE436758B (sv) 1985-01-21

Family

ID=12559990

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703760A SE436758B (sv) 1976-04-07 1977-03-31 Sett att framstella nya antracyklin-glykosid-antibiotika, benemnda ma 144-m 711 och ma 144-m 712, genom odling av streptomyces galilaeus ma 144-m 711 eller streptomyces sp me 505-he1 och extraktion och rening av bildade

Country Status (11)

Country Link
US (2) US4144329A (sv)
JP (1) JPS52136159A (sv)
BE (1) BE853203A (sv)
CA (1) CA1097238A (sv)
DE (1) DE2715255C3 (sv)
DK (1) DK146342C (sv)
ES (3) ES475579A1 (sv)
FR (1) FR2347381A1 (sv)
GB (1) GB1563432A (sv)
NL (1) NL168557C (sv)
SE (1) SE436758B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123608A (en) * 1977-07-18 1978-10-31 Bristol-Myers Company Antibiotic compound
ZA802929B (en) * 1979-05-22 1981-05-27 Hoffmann La Roche Novel tetracyclic compounds and process for the preparation thereof
JPS6023679B2 (ja) * 1979-07-13 1985-06-08 メルシャン株式会社 ロドマイシン群抗生物質とその製造法
DE3071391D1 (en) * 1979-09-07 1986-03-13 Sanraku Ocean Co 2-hydroxyaclacinomycin a, pharmaceutical composition containing it; 2-hydroxyaclavinone and fermentative process for preparing same
JPS5767518A (en) * 1980-09-17 1982-04-24 Yamasa Shoyu Co Ltd Radiosensitizing agent or agent for increasing effect of radiomimetic substance
CH648327A5 (de) * 1980-10-16 1985-03-15 Hoffmann La Roche Anthracycline.
CA1187434A (en) * 1981-08-11 1985-05-21 Akihiro Yoshimoto Anthracycline antibiotics and their preparation method
JPS6133194A (ja) * 1984-07-25 1986-02-17 Sanraku Inc 新規アントラサイクリン抗生物質
US20050208037A1 (en) * 2003-10-21 2005-09-22 Board Of Regents, The University Of Texas System Thioredoxin increases redox-cycling of anticancer agents thereby sensitizes cancer cells to apoptosis
CN104644631A (zh) * 2015-01-31 2015-05-27 云南省第一人民医院 新乌头碱对k562细胞生物学特性的改变

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB846130A (en) 1956-03-23 1960-08-24 Ciba Ltd New antibiotic and derivatives and salts thereof, preparations containing the same and process for the manufacture of these substances
US3864480A (en) * 1974-05-06 1975-02-04 Merck & Co Inc Cinerubin A and B As Antiparasitic Agents
JPS5134915B2 (sv) * 1974-07-27 1976-09-29
JPS5323961A (en) * 1976-08-16 1978-03-06 Microbial Chem Res Found Antitumors

Also Published As

Publication number Publication date
ES469424A1 (es) 1979-04-01
DE2715255A1 (de) 1977-11-10
BE853203A (fr) 1977-08-01
JPS52136159A (en) 1977-11-14
CA1097238A (en) 1981-03-10
US4144329A (en) 1979-03-13
GB1563432A (en) 1980-03-26
FR2347381B1 (sv) 1980-10-17
DK146342C (da) 1984-04-09
DK146342B (da) 1983-09-12
NL168557C (nl) 1982-04-16
SE436758B (sv) 1985-01-21
NL7703753A (nl) 1977-10-11
ES475579A1 (es) 1978-08-01
ES469423A1 (es) 1979-04-01
JPS5438100B2 (sv) 1979-11-19
DK152977A (da) 1977-10-08
US4219622A (en) 1980-08-26
DE2715255C3 (de) 1979-08-30
FR2347381A1 (fr) 1977-11-04
DE2715255B2 (de) 1979-01-04

Similar Documents

Publication Publication Date Title
SE7710972L (sv) Nya antitumor-antracyklinantibiotika
SE7508450L (sv) Antitumorantibiotika aklacinomycin a och b.
ES475854A1 (es) Un procedimiento para preparar derivados de glicosido de pleuromutilina
SE7703760L (sv) Antibiotika
AU7581987A (en) Ecteinascidins 729, 743, 745, 759a, 759b and 770
SE7709234L (sv) Antitumorantibiotika
ATE37394T1 (de) Antitumor-antibiotika.
DE3588213D1 (de) Antitumorale Antibiotika (Komplex LL-E-33288)
SE7706350L (sv) Antitumor -antibiotika
SE8000842L (sv) Nya antibiotika
ES480405A1 (es) Un procedimiento para la obtencion de sustancias antibioti- cas o sus derivados.
JPS5799200A (en) Production of acranomycins
ZA815330B (en) New antibiotic,mf 266 substance and production thereof
FR2324310B1 (sv)
ES8602130A1 (es) Un procedimiento para la preparacion de una macrolida
ATE36712T1 (de) Nargenicin c1.
ES8104400A1 (es) Un procedimiento para la produccion de un nuevo antibiotico designado com substancia bn-183 b.
ES459663A1 (es) Procedimiento para preparar antibioticos depsispeptidos de neoviridogriseinas i, ii y iii.
ATE41011T1 (de) Macrolide antibiotika.
IN164553B (sv)
FR2024316B1 (sv)
JPS57132887A (en) Antibiotic s/433

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7703760-4

Effective date: 19890427

Format of ref document f/p: F